Primary Site >> Pancreatic Cancer
Gene >> MUC1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Papillary-cystic neoplasm of the pancreas. PMID: 534384 |
Ref: Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. PMID: 6193872 Ref: Gastrointestinal tumor markers, other than carcinoembryonic antigen, and alpha fetal protein. PMID: 6883374 |
Ref: Experimental pancreatic carcinoma as a model of human pancreatic carcinoma. PMID: 6423332 |
Ref: [CA 15-3 is present as a novel tumor marker in the sera of patients with breast cancer and other malignancies]. PMID: 3865634 |
Ref: Characterization of a new primary human pancreatic tumor line. PMID: 3754176 Ref: Pancreatic carcinoma and Trousseau's syndrome: experience at a large cancer center. PMID: 3958764 |
Ref: Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing epitopes consisting of sialyl or sialyl-fucosyl type 1 chain. PMID: 2454154 |
Ref: [Clinical relevance of tumor markers]. PMID: 2672606 Ref: Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. PMID: 2674949 |
Ref: Epithelial markers in pancreatic carcinoma: immunoperoxidase localisation of DD9, CEA, EMA and CAM 5.2. PMID: 1696288 |
Ref: Preparation of pancreatic cancer-associated mucin expressing CA19-9, CA50, Span-1, sialyl SSEA-1, and Dupan-2. PMID: 1682994 Ref: Co-expression of X-hapten-like antigen and antigen YH206 on mucin molecules. PMID: 1706671 Ref: Expression of the human mucin gene, Muc 1, in normal tissues and metastatic pancreatic tumors. PMID: 1787340 Ref: Transfection of the human Muc 1 mucin gene into a poorly differentiated human pancreatic tumor cell line, Panc1: integration, expression and ultrastructural changes. PMID: 1814933 Ref: Differential mucin gene expression in human pancreatic and colon cancer cells. PMID: 2064602 |
Ref: Expression of the human MUC1 mucin cDNA in a hamster pancreatic tumor cell line HP-1. PMID: 1289420 Ref: Clinical evaluation of pancreatic cancer-associated mucin expressing CA19-9, CA50, Span-1, sialyl SSEA-1, and Dupan-2. PMID: 1359630 Ref: Tissue-specific expression of a human polymorphic epithelial mucin (MUC1) in transgenic mice. PMID: 1372533 Ref: Expression of tumor-associated epitopes on Epstein-Barr virus-immortalized B-cells and Burkitt's lymphomas transfected with epithelial mucin complementary DNA. PMID: 1382849 Ref: Differences in expression of SPan-1 and CA15-3 antigens in blood and tissues. PMID: 1428228 |
Ref: Expression of CA19-9, DU-PAN-2, and SPan-1 antigens on two types of normal salivary mucins. PMID: 7518709 Ref: Multiple forms of intracellular and secreted mucins in a pancreatic cancer cell line. PMID: 7679052 Ref: Specific and effective T-cell recognition of cells transfected with a truncated human mucin cDNA. PMID: 7690213 Ref: Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors. PMID: 8384065 Ref: Analysis of the tissue-specific promoter of the MUC1 gene. PMID: 8387509 Ref: Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA. PMID: 8393050 |
Ref: Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients. PMID: 7514493 Ref: E-selectin binding by pancreatic tumor cells is inhibited by cancer sera. PMID: 7515860 Ref: Cytokeratins and mucins as molecular markers of cell differentiation and neoplastic transformation in the exocrine pancreas. PMID: 7524652 Ref: Serological pancreatic tumor markers and the MUC1 apomucin. PMID: 7846010 Ref: N-acetylgalactosamine glycosylation of MUC1 tandem repeat peptides by pancreatic tumor cell extracts. PMID: 8033093 Ref: Altered expression of MUC2, MUC4, and MUC5 mucin genes in pancreas tissues and cancer cell lines. PMID: 8143972 Ref: Expression of MUC1, MUC2, MUC3 and MUC4 mucin mRNAs in human pancreatic and intestinal tumor cell lines. PMID: 8157358 Ref: [Molecular biological analyses of mucin core proteins and their clinical application]. PMID: 8311484 Ref: Lack of tissue-specificity of mucin markers in a lung-cancer model - biochemical approach. PMID: 21559722 |
Ref: Cystic fibrosis and pancreatic cancer cells synthesize and secrete MUC1 type mucin gene product. PMID: 7545050 Ref: Association of sialyl-Lewis(a) and sialyl-Lewis(x) with MUC-1 apomucin ina pancreatic cancer cell line. PMID: 7627976 Ref: Rare primary signet ring carcinoma of the pancreas. PMID: 7643842 Ref: In situ hybridization shows distinct patterns of mucin gene expression in normal, benign, and malignant pancreas tissues. PMID: 7657125 Ref: New pancreas cancers cell lines that represent distinct stages of ductal differentiation. PMID: 7723277 Ref: Effects of VIP on the regulation of mucin secretion in cultured human pancreatic cancer cells (Capan-1). PMID: 7757305 Ref: Mucoepidermoid carcinoma of the pancreas: report of a case. PMID: 8555707 |
Ref: [New mucin core protein genes and their clinical application]. PMID: 8641670 Ref: A novel monoclonal antibody specific for sialylated MUC1 mucin. PMID: 8641986 Ref: Intraductal oncocytic papillary neoplasms of the pancreas. PMID: 8712298 Ref: [Adoptive immunotherapy for pancreatic cancer, using MUC1 specific CTL]. PMID: 8886044 Ref: Expression of MUC apomucins in normal pancreas and pancreatic tumours. PMID: 8976874 |
Ref: Diagnosis of mucin-producing tumor of the pancreas with an intraductal ultrasonographic system. PMID: 8979219 Ref: Prospective study of CAM 17.1/WGA mucin assay for serological diagnosis of pancreatic cancer. PMID: 9033465 Ref: MUC2 gene expression is found in noninvasive tumors but not in invasive tumors of the pancreas and liver: its close relationship with prognosis of the patients. PMID: 9042800 Ref: Therapeutic antitumor response after immunization with an admixture of recombinant vaccinia viruses expressing a modified MUC1 gene and the murine T-cell costimulatory molecule B7. PMID: 9101412 Ref: Prognostic significance of preimmunotherapy serum CA27.29 (MUC-1) mucin level after active specific immunotherapy of metastatic adenocarcinoma patients. PMID: 9101416 Ref: Expression of mucin-like carcinoma-associated antigen in the cyst fluid differentiates mucinous from nonmucinous pancreatic cysts. PMID: 9128321 Ref: Expression of mucin-associated tumor antigens is altered by cell density. PMID: 9247290 |
Ref: Screening of anti-MUC1 antibodies for reactivity with native (ascites) and recombinant (baculovirus) MUC1 and for blocking MUC1 specific cytotoxic T-lymphocytes. PMID: 9422100 Ref: Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model. PMID: 9443411 Ref: Naturally processed class II epitope from the tumor antigen MUC1 primes human CD4+ T cells. PMID: 9823312 |
Ref: Organ-specific pancreatic tumor growth properties and tumor immunity. PMID: 10022473 Ref: Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies. PMID: 10361129 Ref: Single-chain antibodies in pancreatic cancer. PMID: 10415872 Ref: Sarcomatoid carcinoma of the pancreas: a case report with immunohistochemical study. PMID: 10417690 Ref: Expression of core 2 beta-1,6-N-acetylglucosaminyltransferase in a human pancreatic cancer cell line results in altered expression of MUC1 tumor-associated epitopes. PMID: 10455130 Ref: Immunoregulation in pancreatic cancer patients. PMID: 10478644 Ref: Sialylated MUC1 mucin expression in normal pancreas, benign pancreatic lesions, and pancreatic ductal adenocarcinoma. PMID: 10521973 Ref: Differential MUC 1 expression in normal and neoplastic human pancreatic tissue. An immunohistochemical study of 60 samples. PMID: 10549250 |
Ref: [Histopathologic problems in the classification of pancreatic carcinoma]. PMID: 10734635 Ref: Forskolin and phorbol ester have opposite effects on the expression of mucin-associated sialyl-Lewis(a) in pancreatic cancer cells. PMID: 10741304 Ref: Foamy gland pattern of pancreatic ductal adenocarcinoma: a deceptively benign-appearing variant. PMID: 10757396 Ref: K-ras gene mutations and loss of heterozygosity at the p53 gene locus relative to histological characteristics of mucin-producing tumors of the pancreas. PMID: 10923915 Ref: Mice with spontaneous pancreatic cancer naturally develop MUC-1-specific CTLs that eradicate tumors when adoptively transferred. PMID: 10975866 Ref: Forskolin increases the expression of the pancreatic tumor antigen, Nd2, and uptake of Nd2 antibody. PMID: 11029487 Ref: Enhancement of metastatic properties of pancreatic cancer cells by MUC1 gene encoding an anti-adhesion molecule. PMID: 11058865 Ref: Mucins in the diagnosis and therapy of pancreatic cancer. PMID: 11102566 |
Ref: Influence of organ site and tumor cell type on MUC1-specific tumor immunity. PMID: 11157856 Ref: A case report of cribriform carcinoma of the pancreas with long time survival. PMID: 11268983 Ref: CA19-9 epitope a possible marker for MUC-1/Y protein. PMID: 11295060 Ref: Biochemical characterization of the soluble form of tumor antigen MUC1 isolated from sera and ascites fluid of breast and pancreatic cancer patients. PMID: 11300473 Ref: MUC1-specific cytotoxic T lymphocytes eradicate tumors when adoptively transferred in vivo. PMID: 11300482 Ref: Suppressed T-cell receptor zeta chain expression and cytokine production in pancreatic cancer patients. PMID: 11300494 Ref: Localization of pancreatic cancer with radiolabeled monoclonal antibody PAM4. PMID: 11418312 Ref: The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. PMID: 11420467 Ref: Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. PMID: 11751498 Ref: MUC1-specific CTLs are non-functional within a pancreatic tumor microenvironment. PMID: 12820727 |
Ref: Combined gemcitabine and radioimmunotherapy for the treatment of pancreatic cancer. PMID: 11774294 Ref: Expression of maspin in pancreatic neoplasms: application of maspin immunohistochemistry to the differential diagnosis. PMID: 11893038 Ref: De novo expression of the Muc2 gene in pancreas carcinoma cells is triggered by promoter demethylation. PMID: 11893907 Ref: The mucin profile of noninvasive and invasive mucinous cystic neoplasms of the pancreas. PMID: 11914624 Ref: [Immunotherapy for unresectable pancreatic cancer]. PMID: 11915728 Ref: New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy. PMID: 12015744 Ref: Molecular requirements for CD8-mediated rejection of a MUC1-expressing pancreatic carcinoma: implications for tumor vaccines. PMID: 12111121 Ref: Biliary papillary neoplasm of the liver. PMID: 12168796 Ref: Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas. PMID: 12360467 Ref: Regulation of herpes simplex virus 1 replication using tumor-associated promoters. PMID: 12368679 Ref: The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. PMID: 12379756 Ref: Dendritic cell-tumor cell fusion and staphylococcal enterotoxin B treatment in a pancreatic tumor model. PMID: 12429175 Ref: Minute invasive ductal carcinoma of the residual pancreas after distal pancreatectomy for intraductal papillary-mucinous tumor. PMID: 12622431 |
Ref: Screening of genes specifically activated in the pancreatic juice ductal cells from the patients with pancreatic ductal carcinoma. PMID: 11854626 Ref: Circulating anti-MUC1 IgG antibodies as a favorable prognostic factor for pancreatic cancer. PMID: 12455059 Ref: A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform. PMID: 12692724 Ref: Expression of mucins and cytokeratins in primary carcinomas of the digestive system. PMID: 12748245 Ref: Screening of genes specifically activated in the pancreatic juice ductal cells from the patients with pancreatic ductal carcinoma. PMID: 12824920 Ref: Nuclear association of the cytoplasmic tail of MUC1 and beta-catenin. PMID: 12832415 Ref: Ductal adenocarcinoma of the pancreas with huge cystic degeneration: a lesion to be distinguished from pseudocyst and mucinous cystadenocarcinoma. PMID: 12894360 Ref: Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell line. PMID: 12941828 Ref: Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. PMID: 13679454 Ref: Clinicopathological features of pancreatic intraepithelial neoplasias and their relationship to intraductal papillary-mucinous tumors. PMID: 14505145 Ref: Low-dose radioimmunotherapy ((90)Y-PAM4) combined with gemcitabine for the treatment of experimental pancreatic cancer. PMID: 14506191 Ref: Increased expression of MUC1 in advanced pancreatic cancer. PMID: 14714254 Ref: Expression of MUC5AC and MUC6 in invasive ductal carcinoma of the pancreas and relationship with prognosis. PMID: 15235131 |
Ref: Expression and localization of MUC1, MUC2, MUC5AC and small intestinal mucin antigen in pancreatic tumors. PMID: 14654947 Ref: Combined 90Yttrium-DOTA-labeled PAM4 antibody radioimmunotherapy and gemcitabine radiosensitization for the treatment of a human pancreatic cancer xenograft. PMID: 14991585 Ref: YY1 transcription factor is not responsible for the negative regulation of hamster Muc1 transcription. PMID: 15015602 Ref: Serous cystic neoplasms of the pancreas: an immunohistochemical analysis revealing alpha-inhibin, neuron-specific enolase, and MUC6 as new markers. PMID: 15104296 Ref: Characterization of FAMPAC, a newly identified human pancreatic carcinoma cell line with a hereditary background. PMID: 15112280 Ref: MUC1 and MUC2 in pancreatic neoplasia. PMID: 15113850 Ref: Down-regulation of the human tumor antigen mucin by gemcitabine on the pancreatic cancer cell line capan-2. PMID: 15161033 Ref: Improved targeting of pancreatic cancer: experimental studies of a new bispecific antibody, pretargeting enhancement system for immunoscintigraphy. PMID: 15161715 Ref: Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas. PMID: 15223952 Ref: Comprehensive proteomic analysis of human pancreatic juice. PMID: 15473694 Ref: Multiple roles of mucins in pancreatic cancer, a lethal and challenging malignancy. PMID: 15494719 Ref: MUC1 expression in primary and metastatic pancreatic cancer cells for in vitro treatment by (213)Bi-C595 radioimmunoconjugate. PMID: 15599383 Ref: (111)In/(125/131)I-Labeled anti-mucin-1 murine, chimeric or humanized antibody hPAM4 PMID: 21834178 Ref: (111)In-Labeled Ac-Phe-Lys(DTPA)-Tyr-Lys(DTPA)-NH2 (IMP-156) PMID: 21834179 Ref: (99m)Tc-Ac-Lys(DTPA)-Tyr-Lys(DTPA)-Lys(thiosemicarbazonyl-glyoxyl-cysteinyl-)-NH2 (IMP-192) PMID: 21834181 Ref: (125)I-Labeled anti-mucin 1 bispecific antibody bsPAM4 PMID: 21834182 Ref: (111)In-Labeled 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid (DOTA)-d-Tyr-d-Lys(HSG)-d-Glu-d-Lys(HSG)-NH2 (IMP-288) PMID: 21882402 Ref: 125I-Labeled trivalent, bispecific monoclonal antibody construct TF10 that targets mucin-1 and is reactive against a histamine-succinyl-glycine hapten IMP-288 PMID: 21882406 |
Ref: Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer. PMID: 15372205 Ref: Transcriptional tumor-selective promoter targeting of E. coli purine nucleoside phosphorylase for pancreatic cancer suicide gene therapy. PMID: 15580629 Ref: Immunohistochemistry as a tool in the differential diagnosis of ovarian tumors: an update. PMID: 15626916 Ref: Panniculitis after vaccination against CEA and MUC1 in a patient with pancreatic cancer. PMID: 15629278 Ref: [Pancreatic ductal adenocarcinoma and its precursors]. PMID: 15630571 Ref: Mucinous cystic carcinoma of the pancreas: a unique cell line and xenograft model of a preinvasive lesion. PMID: 15688169 Ref: Intraductal tubular neoplasms of the pancreas: histogenesis and differentiation. PMID: 15714133 Ref: RPL38, FOSL1, and UPP1 are predominantly expressed in the pancreatic ductal epithelium. PMID: 15714138 Ref: Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2. PMID: 15725805 Ref: Amplification and functional characterization of MUC1 promoter and gene-virotherapy via a targeting adenoviral vector expressing hSSTR2 gene in MUC1-positive Panc-1 pancreatic cancer cells in vitro. PMID: 15754023 Ref: Intestinal and oncocytic variants of pancreatic intraepithelial neoplasia. A morphological and immunohistochemical study. PMID: 15806512 Ref: MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT). PMID: 15816444 Ref: Biological similarities and differences between pancreatic intraepithelial neoplasias and intraductal papillary mucinous neoplasms. PMID: 15879625 Ref: Management of the mucin filled bile duct. A complication of intraductal papillary mucinous tumor of the pancreas. PMID: 15883476 Ref: MZF-1 and DbpA interact with DNase I hypersensitive sites that correlate with expression of the human MUC1 mucin gene. PMID: 15893750 Ref: Pancreatic ductal adenocarcinomas with cystic features: neither rare nor uniform. PMID: 15920540 Ref: Intercalated duct cell is starting point in development of pancreatic ductal carcinoma? PMID: 16018800 Ref: Immunohistochemical studies of mucinous mammary carcinomas and their metastases. PMID: 16033095 Ref: Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects. PMID: 16183479 |
Ref: Quantitative analysis of MUC1 and MUC5AC mRNA in pancreatic juice for preoperative diagnosis of pancreatic cancer. PMID: 16052519 Ref: New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis. PMID: 16344318 Ref: Serous cystic neoplasms of the pancreas: a clinicopathologic and immunohistochemical analysis. PMID: 16412036 Ref: PankoMab: a potent new generation anti-tumour MUC1 antibody. PMID: 16485130 Ref: Diagnostic utility of mucin profile in fine-needle aspiration specimens of the pancreas: an immunohistochemical study with surgical pathology correlation. PMID: 16628655 Ref: [Diagnosis and differential diagnosis of intraductal papillary mucinous neoplasm of pancreas]. PMID: 16630480 Ref: RNA interference suppression of MUC1 reduces the growth rate and metastatic phenotype of human pancreatic cancer cells. PMID: 16707592 Ref: Adenovirus-mediated and targeted expression of the sodium-iodide symporter permits in vivo radioiodide imaging and therapy of pancreatic tumors. PMID: 16776574 Ref: Immunohistochemical study of the association between the progression of pancreatic ductal lesions and the expression of MUC1, MUC2, MUC5AC, and E-cadherin. PMID: 16789413 Ref: Immunohistochemical expression of 14-3-3 sigma protein in intraductal papillary-mucinous tumor and invasive ductal carcinoma of the pancreas. PMID: 16886641 Ref: Cigarette smoke-induced differential expression of the genes involved in exocrine function of the rat pancreas. PMID: 17079941 Ref: A series of 64 cases of pancreatic cystic neoplasia from an institutional study of China. PMID: 17143961 |
Ref: Microparticle-associated tissue factor activity: a link between cancer and thrombosis? PMID: 17166244 Ref: Multiplexed analysis of glycan variation on native proteins captured by antibody microarrays. PMID: 17417647 Ref: Solid type clear cell carcinoma of the pancreas: differential diagnosis of an unusual case and review of the literature. PMID: 17453235 Ref: Mucin expression profile in pancreatic cancer and the precursor lesions. PMID: 17520199 Ref: [Clinicopathologic analysis of 92 cases of pancreatic cystic neoplasm]. PMID: 17535681 Ref: Ectopic hepatocellular carcinoma arising from pancreas: a case report and review of the literature. PMID: 17696261 Ref: Diagnostic value of mucins (MUC1, MUC2 and MUC5AC) expression profile in endoscopic ultrasound-guided fine-needle aspiration specimens of the pancreas. PMID: 17708554 Ref: Progress on molecular markers of pancreatic cancer. PMID: 17762556 Ref: Concomitant pancreatic activation of Kras(G12D) and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN. PMID: 17785207 Ref: Detection of micrometastases in peritoneal washings of pancreatic cancer patients by the reverse transcriptase polymerase chain reaction. PMID: 17879123 Ref: In vivo radioiodide imaging and treatment of pancreatic cancer xenografts after MUC1 promoter-driven expression of the human sodium-iodide symporter. PMID: 17912014 Ref: Mucin impedes cytotoxic effect of 5-FU against growth of human pancreatic cancer cells: overcoming cellular barriers for therapeutic gain. PMID: 17912239 Ref: MUC1 is a counter-receptor for myelin-associated glycoprotein (Siglec-4a) and their interaction contributes to adhesion in pancreatic cancer perineural invasion. PMID: 17974963 Ref: Anaplastic carcinoma of the pancreas associated with a mucinous cystic adenocarcinoma. A case report and review of the literature. PMID: 17993730 Ref: Poxvirus-based vaccine therapy for patients with advanced pancreatic cancer. PMID: 18039393 Ref: PAM4-reactive MUC1 is a biomarker for early pancreatic adenocarcinoma. PMID: 18094420 Ref: [Human mucin 1 promoter drives human sodium/iodide symporter gene targeting expression in pancreatic carcinoma cells]. PMID: 18167272 |
Ref: Mucin-type O-glycosylation and its potential use in drug and vaccine development. PMID: 17988798 Ref: Multifunctional antibodies by the Dock-and-Lock method for improved cancer imaging and therapy by pretargeting. PMID: 18077530 Ref: Adoptive immunotherapy for pancreatic cancer using MUC1 peptide-pulsed dendritic cells and activated T lymphocytes. PMID: 18383873 Ref: Clear cell carcinoma of the pancreas: histopathologic features and a unique biomarker: hepatocyte nuclear factor-1beta. PMID: 18536653 Ref: Adoptive immunotherapy for pancreatic cancer: cytotoxic T lymphocytes stimulated by the MUC1-expressing human pancreatic cancer cell line YPK-1. PMID: 18575732 Ref: The foamy variant of pancreatic intraepithelial neoplasia. PMID: 18620991 Ref: Phosphorylation of MUC1 by Met modulates interaction with p53 and MMP1 expression. PMID: 18625714 Ref: Translational research in pancreatic cancer. Highlights from the "44th ASCO Annual Meeting". Chicago, IL, USA. May 30 - June 3, 2008. PMID: 18648129 Ref: Radioimmunoscintigraphy of pancreatic cancer in tumor-bearing athymic nude mice using (99m)technetium-labeled anti-KL-6/MUC1 antibody. PMID: 18683568 Ref: MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma. PMID: 18713982 Ref: [Immunohistochemical study of mucins in chronic pancreatitis and ductal adenocarcinoma of the pancreas]. PMID: 18807519 Ref: Surgical outcome of adenosquamous carcinoma of the pancreas. PMID: 19058301 Ref: A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors. PMID: 19129927 Ref: Precursor lesions of pancreatic cancer. PMID: 20485640 Ref: Effect of benzyl-N-acetyl-alpha-galactosaminide on KL-6 mucin expression and invasive properties of a human pancreatic carcinoma cell line. PMID: 22504721 |
Ref: Histologic, immunohistochemical, and molecular classification of 52 IPMNs of the pancreas. PMID: 18813127 Ref: Mucin overexpression limits the effectiveness of 5-FU by reducing intracellular drug uptake and antineoplastic drug effects in pancreatic tumours. PMID: 19046630 Ref: Proteomic analysis of human bile from malignant biliary stenosis induced by pancreatic cancer. PMID: 19055478 Ref: Progression of pancreatic adenocarcinoma is significantly impeded with a combination of vaccine and COX-2 inhibition. PMID: 19109152 Ref: Pancreatic serous microcystic adenoma with extensive oncocytic change. PMID: 19154264 Ref: Chronic pancreatitis and the differential diagnosis versus pancreatic cancer. PMID: 19260744 Ref: Associations between selected biomarkers and prognosis in a population-based pancreatic cancer tissue microarray. PMID: 19276352 Ref: Screening for early pancreatic ductal adenocarcinoma: an urgent call! PMID: 19287101 Ref: The prevalence and nature of glycan alterations on specific proteins in pancreatic cancer patients revealed using antibody-lectin sandwich arrays. PMID: 19377061 Ref: MUC1 Knockdown With RNA Interference Inhibits Pancreatic Cancer Growth. PMID: 19482310 Ref: Induction of protective and therapeutic anti-pancreatic cancer immunity using a reconstructed MUC1 DNA vaccine. PMID: 19534821 Ref: Mucin glycosylation is altered by pro-inflammatory signaling in pancreatic-cancer cells. PMID: 19714813 Ref: Clear cell carcinoma of the pancreas--a case report and review of the literature. PMID: 19809568 Ref: Resection of four synchronous invasive ductal carcinomas in the pancreas head and body associated with pancreatic intraepithelial neoplasia: report of a case. PMID: 19997809 Ref: Clinicopathology of sialomucin: MUC1, particularly KL-6 mucin, in gastrointestinal, hepatic and pancreatic cancers. PMID: 20103851 |
Ref: Combination of MUC5ac and WT-1 immunohistochemistry is useful in distinguishing pancreatic ductal carcinoma from ovarian serous carcinoma in effusion cytology. PMID: 19856421 Ref: Ampullary cancer. PMID: 20168227 Ref: Induction of antigen-specific CTL and antibody responses in mice by a novel recombinant tandem repeat DNA vaccine targeting at mucin 1 of pancreatic cancer. PMID: 20229033 Ref: [A case of metastatic pancreatic cancer with a remarkable response to combination therapy of gemcitabine and adoptive immune cell therapy]. PMID: 20332697 Ref: Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms. PMID: 20395854 Ref: Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express alpha-gal epitopes: a novel approach to immunotherapy in pancreatic cancer. PMID: 20530670 Ref: The reactive tumor microenvironment: MUC1 signaling directly reprograms transcription of CTGF. PMID: 20697347 Ref: Endoscopic ultrasound-guided fine needle aspiration cytology diagnosis of solid pseudopapillary tumor of the pancreas: a report of 3 cases. PMID: 20968159 Ref: Predictive factors associated with malignancy of intraductal papillary mucinous pancreatic neoplasms. PMID: 21072900 |
Ref: Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas. PMID: 20717734 Ref: O-glycosylation of MUC1 mucin in prostate cancer and the effects of its expression on tumor growth in a prostate cancer xenograft model. PMID: 20872286 Ref: MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition. PMID: 21102519 Ref: Anti-MUC1 antibody inhibits EGF receptor signaling in cancer cells. PMID: 21219855 Ref: Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells. PMID: 21258405 Ref: Carbohydrate markers of pancreatic cancer. PMID: 21265800 Ref: Structural analysis of the cancer-specific promoter in mesothelin and in other genes overexpressed in cancers. PMID: 21288909 Ref: A novel tumor-associated pancreatic glycoprotein is internalized by human dendritic cells and induces their maturation. PMID: 21346236 Ref: Similarities and differences between intraductal papillary tumors of the bile duct with and without macroscopically visible mucin secretion. PMID: 21412069 Ref: Localization of the most severely dysplastic/invasive lesions and mucin phenotypes in intraductal papillary mucinous neoplasm of the pancreas. PMID: 21441843 Ref: Expression of KL-6/MUC1 in pancreatic ductal carcinoma and its potential relationship with beta-catenin in tumor progression. PMID: 21466814 Ref: Pancreatic ductal adenocarcinoma mice lacking mucin 1 have a profound defect in tumor growth and metastasis. PMID: 21558393 Ref: Expression of KL-6/MUC1 in pancreatic cancer tissues and its potential involvement in tumor metastasis. PMID: 21617869 Ref: Tumor-infiltrating neutrophils in pancreatic neoplasia. PMID: 21822201 Ref: A minute pancreatic ductal adenocarcinoma with lipomatous pseudohypertrophy of the pancreas. PMID: 21904072 Ref: Human dendritic cells transfected with amplified MUC1 mRNA stimulate cytotoxic T lymphocyte responses against pancreatic cancer in vitro. PMID: 21950745 Ref: [Colloid carcinoma of pancreas: a clinicopathologic study of 4 cases]. PMID: 22336159 Ref: Differential gene expression analysis of peripheral blood mononuclear cells reveals novel test for early detection of pancreatic cancer. PMID: 22820136 Ref: Targeted alpha therapy approach to the management of pancreatic cancer. PMID: 24212784 |
Ref: Clinical significance of MUC1, MUC2 and CK17 expression patterns for diagnosis of pancreatobiliary arcinoma. PMID: 21438791 Ref: A phase I pilot trial of MUC1-peptide-pulsed dendritic cells in the treatment of advanced pancreatic cancer. PMID: 21932124 Ref: Frequency of subtypes of biliary intraductal papillary mucinous neoplasm and their MUC1, MUC2, and DPC4 expression patterns differ from pancreatic intraductal papillary mucinous neoplasm. PMID: 22112419 Ref: MUC1 regulates PDGFA expression during pancreatic cancer progression. PMID: 22266848 Ref: Multimarker gene analysis of circulating tumor cells in pancreatic cancer patients: a feasibility study. PMID: 22270149 Ref: Mucin-based targeted pancreatic cancer therapy. PMID: 22372499 Ref: Intratumoral delivery of CpG-conjugated anti-MUC1 antibody enhances NK cell anti-tumor activity. PMID: 22543528 Ref: Genetic markers of malignant transformation in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysis. PMID: 22750975 Ref: A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers. PMID: 22792233 Ref: MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer. PMID: 22869720 Ref: MUC1c regulates cell survival in pancreatic cancer by preventing lysosomal permeabilization. PMID: 22912777 Ref: Intraductal tubular neoplasms of the bile ducts. PMID: 23073323 Ref: Duodenal carcinoma from a duodenal diverticulum mimicking pancreatic carcinoma. PMID: 23093061 Ref: Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy. PMID: 23102107 Ref: Mucoepidermoid carcinoma of the pancreas: a case report and a review of literature. PMID: 23826019 |
Ref: AGR2 is a SMAD4-suppressible gene that modulates MUC1 levels and promotes the initiation and progression of pancreatic intraepithelial neoplasia. PMID: 22945649 Ref: MUC1 enhances hypoxia-driven angiogenesis through the regulation of multiple proangiogenic factors. PMID: 23108411 Ref: The use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancer. PMID: 23335066 Ref: Aberrant expression of mucin core proteins and o-linked glycans associated with progression of pancreatic cancer. PMID: 23446997 Ref: Pathohistological subtype predicts survival in patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas. PMID: 23532107 Ref: Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype. PMID: 23532108 Ref: Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer. PMID: 23652307 Ref: Activated EGFR stimulates MUC1 expression in human uterine and pancreatic cancer cell lines. PMID: 23686469 Ref: Novel curcumin-loaded magnetic nanoparticles for pancreatic cancer treatment. PMID: 23704793 Ref: Expression of core 3 synthase in human pancreatic cancer cells suppresses tumor growth and metastasis. PMID: 23754791 Ref: MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes. PMID: 23774063 Ref: Intraductal tubulopapillary neoplasms of the pancreas: case report and review of the literature. PMID: 23832407 Ref: [Intraductal tubulopapillary neoplasm of the pancreas: a clinicopathologic study of 6 cases]. PMID: 23928532 Ref: Prediction of glycan motifs using quantitative analysis of multi-lectin binding: Motifs on MUC1 produced by cultured pancreatic cancer cells. PMID: 23956151 Ref: Glycan elongation beyond the mucin associated Tn antigen protects tumor cells from immune-mediated killing. PMID: 24039759 Ref: MUC1 regulates expression of multiple microRNAs involved in pancreatic tumor progression, including the miR-200c/141 cluster. PMID: 24143167 Ref: Novel pancreatic cancer cell lines derived from genetically engineered mouse models of spontaneous pancreatic adenocarcinoma: applications in diagnosis and therapy. PMID: 24278292 |
Ref: Intraductal tubulopapillary neoplasm of the pancreas on fine needle aspiration: case report with differential diagnosis. PMID: 22807417 Ref: Pancreatic cancer in the remnant pancreas following primary pancreatic resection. PMID: 23975591 Ref: PPARgamma E3 ubiquitin ligase regulates MUC1-C oncoprotein stability. PMID: 24292674 Ref: Is intraductal tubulopapillary neoplasia a new entity in the spectrum of familial pancreatic cancer syndrome? PMID: 24317685 Ref: Intraductal tubulopapillary neoplasm with expansile invasive carcinoma of the pancreas diagnosed by endoscopic ultrasonography-guided fine needle aspiration: a case report. PMID: 24339429 Ref: Interactions between MUC1 and p120 catenin regulate dynamic features of cell adhesion, motility, and metastasis. PMID: 24371222 Ref: Case report: Intraductal tubulopapillary neoplasm of the pancreas with unique clear cell phenotype. PMID: 24443801 Ref: Pancreatic Cancer Cells Isolated from Muc1-Null Tumors Favor the Generation of a Mature Less Suppressive MDSC Population. PMID: 24605110 Ref: Microfluidic immunocapture of circulating pancreatic cells using parallel EpCAM and MUC1 capture: characterization, optimization and downstream analysis. PMID: 24681997 Ref: Diagnosis of pancreatic neoplasms using a novel method of DNA methylation analysis of mucin expression in pancreatic juice. PMID: 24714692 Ref: The role of PAM4 in the management of pancreatic cancer: diagnosis, radioimmunodetection, and radioimmunotherapy. PMID: 24818166 Ref: Induction of antigen-specific cytotoxic T lymphocytes by fusion cells generated from allogeneic plasmacytoid dendritic and tumor cells. PMID: 24819411 Ref: Adoptive immunotherapy with MUC1-mRNA transfected dendritic cells and cytotoxic lymphocytes plus gemcitabine for unresectable pancreatic cancer. PMID: 24947606 Ref: MUC1 regulates cyclin D1 gene expression through p120 catenin and beta-catenin. PMID: 24979278 Ref: Inhibition of KL-6/MUC1 glycosylation limits aggressive progression of pancreatic cancer. PMID: 25232251 Ref: Nuclear receptors in pancreatic tumor cells. PMID: 25503115 Ref: Loss of E-cadherin and epithelial to mesenchymal transition is not required for cell motility in tissues or for metastasis. PMID: 25610757 |
Ref: Usefulness of KL-6 in the subtyping of intraductal papillary mucinous neoplasia of the pancreas, including carcinoma, dysplasia, and hyperplasia. PMID: 24908068 Ref: Biphasic Alterations in Expression and Subcellular Localization of MUC1 in Pancreatic Ductal Carcinogenesis in Syrian Hamsters. PMID: 25036908 Ref: MUC1 Promoter-Driven DTA as a Targeted Therapeutic Strategy against Pancreatic Cancer. PMID: 25336517 Ref: The MUC1 oncomucin regulates pancreatic cancer cell biological properties and chemoresistance. Implication of p42-44 MAPK, Akt, Bcl-2 and MMP13 pathways. PMID: 25511698 Ref: NCOA3-mediated upregulation of mucin expression via transcriptional and post-translational changes during the development of pancreatic cancer. PMID: 25531332 Ref: Nonviral oncogenic antigens and the inflammatory signals driving early cancer development as targets for cancer immunoprevention. PMID: 25623216 Ref: A resected case of intraductal tubulopapillary neoplasm of the pancreas: report of a case. PMID: 25692431 Ref: MUC1 selectively targets human pancreatic cancer in orthotopic nude mouse models. PMID: 25815753 Ref: Nanoparticle formulation of ormeloxifene for pancreatic cancer. PMID: 25890768 Ref: Mucin 1 Regulates Cox-2 Gene in Pancreatic Cancer. PMID: 26035123 Ref: Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells. PMID: 26036346 Ref: Matrix metalloproteinase 7 expression in ampullary carcinoma. PMID: 26275245 Ref: Multifocal intraductal tubulopapillary neoplasm of the pancreas with total pancreatectomy: report of a case and review of literature. PMID: 26464736 |
Ref: A Synthetic Glycopeptide Vaccine for the Induction of a Monoclonal Antibody that Differentiates between Normal and Tumor Mammary Cells and Enables the Diagnosis of Human Pancreatic Cancer. PMID: 26800384 Ref: [Intraductal papillary mucinous neoplasm of pancreas: analysis of the clinicopathologic features and prognosis]. PMID: 26956959 Ref: Investigating the role of mucin in the delivery of nanoparticles to cellular models of human cancer disease: an in vitro study. PMID: 26961466 Ref: Immunobiology and immunosurveillance in patients with intraductal papillary mucinous neoplasms (IPMNs), premalignant precursors of pancreatic adenocarcinomas. PMID: 27106024 Ref: Hypoxia-induced oxidative stress promotes MUC4 degradation via autophagy to enhance pancreatic cancer cells survival. PMID: 27109098 Ref: Semiquantitative immunohistochemistry for mucin (MUC1, MUC2, MUC3, MUC4, MUC5AC, and MUC6) profiling of pancreatic ductal cell adenocarcinoma improves diagnostic and prognostic performance. PMID: 27165582 Ref: Identification of FRA-1 as a novel player in pancreatic cancer in cooperation with a MUC1: ERK signaling axis. PMID: 27220889 Ref: DUSP28 links regulation of Mucin 5B and Mucin 16 to migration and survival of AsPC-1 human pancreatic cancer cells. PMID: 27230679 Ref: Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas. PMID: 27283771 Ref: Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma. PMID: 27332733 Ref: Tissue factor-bearing microparticles and CA19.9: two players in pancreatic cancer-associated thrombosis? PMID: 27404454 Ref: Distinct pathways of pathogenesis of intraductal oncocytic papillary neoplasms and intraductal papillary mucinous neoplasms of the pancreas. PMID: 27591765 Ref: Effect of MUC1/beta-catenin interaction on the tumorigenic capacity of pancreatic CD133(+) cells. PMID: 27602113 Ref: Presentation of underglycosylated mucin 1 in pancreatic adenocarcinoma (PDAC) at early stages. PMID: 27725904 Ref: MUC1-ARF-A Novel MUC1 Protein That Resides in the Nucleus and Is Expressed by Alternate Reading Frame Translation of MUC1 mRNA. PMID: 27768738 Ref: Mucins in neoplasms of pancreas, ampulla of Vater and biliary system. PMID: 27795812 |
Ref: Non-ampullary-duodenal carcinomas: clinicopathologic analysis of 47 cases and comparison with ampullary and pancreatic adenocarcinomas. PMID: 27739441 Ref: Surrogate in vitro activation of innate immunity synergizes with interleukin-7 to unleash rapid antigen-driven outgrowth of CD4+ and CD8+ human peripheral blood T-cells naturally recognizing MUC1, HER2/neu and other tumor-associated antigens. PMID: 27974697 Ref: Intraductal Tubulopapillary Neoplasm of the Pancreas: A Clinicopathologic and Immunohistochemical Analysis of 33 Cases. PMID: 27984235 Ref: Galectin-3 is a non-classic RNA binding protein that stabilizes the mucin MUC4 mRNA in the cytoplasm of cancer cells. PMID: 28262838 Ref: Optimized construction of MUC1-VNTRn DNA vaccine and its anti-pancreatic cancer efficacy. PMID: 28454381 Ref: Mucin 1, a signal transduction membrane-bound mucin, is present in human disc tissue and is downregulated in vitro by exposure to IL-1ss or TNF-alpha. PMID: 28482827 Ref: Role of integrin-linked kinase in regulating the protein stability of the MUC1-C oncoprotein in pancreatic cancer cells. PMID: 28692035 Ref: Postoperative Adjuvant Therapy for Resectable Pancreatic Cancer With Gemcitabine and Adoptive Immunotherapy. PMID: 28697053 Ref: MUC-king with HIF May Rewire Pyrimidine Biosynthesis and Curb Gemcitabine Resistance in Pancreatic Cancer. PMID: 28697341 Ref: MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer. PMID: 28697344 Ref: MUC1-Mediated Metabolic Alterations Regulate Response to Radiotherapy in Pancreatic Cancer. PMID: 28720669 Ref: Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells. PMID: 28809118 Ref: Dependence of expression of regulatory master genes of embryonic development in pancreatic cancer cells on the intracellular concentration of the master regulator PDX1. PMID: 28864896 Ref: Decreased expression of MUC1 induces apoptosis and inhibits migration in pancreatic cancer PANC-1 cells via regulation of Slug pathway. PMID: 28869438 Ref: MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer. PMID: 28898700 Ref: A Rare Case of Intraductal Tubulopapillary Neoplasm of the Pancreas Rupturing and Causing Acute Peritonitis. PMID: 29282388 |
Ref: Combination of mAb-AR20.5, anti-PD-L1 and PolyICLC inhibits tumor progression and prolongs survival of MUC1.Tg mice challenged with pancreatic tumors. PMID: 29204701 Ref: Inhibition of MUC1 biosynthesis via threonyl-tRNA synthetase suppresses pancreatic cancer cell migration. PMID: 29328069 Ref: Analysis of sialyl-Lewis x on MUC5AC and MUC1 mucins in pancreatic cancer tissues. PMID: 29408556 Ref: Early detection of pancreatic cancer in mouse models using a novel antibody, TAB004. PMID: 29462213 Ref: Intraductal Tubulopapillary Neoplasm of the Pancreas: An Overview. PMID: 29494224 Ref: Detection and proteomic characterization of extracellular vesicles in human pancreatic juice. PMID: 29550476 Ref: Pancreatic neuroendocrine carcinomas reveal a closer relationship to ductal adenocarcinomas than to neuroendocrine tumors G3. PMID: 29596894 Ref: RT-PCR of peritoneal washings predicts peritoneal pancreatic cancer recurrence. PMID: 29661277 Ref: Yes-associated protein (YAP) in pancreatic cancer: at the epicenter of a targetable signaling network associated with patient survival. PMID: 29682330 Ref: Multilayered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/betacatenin signaling activation (Review). PMID: 29786110 Ref: Targeting dendritic cells in pancreatic ductal adenocarcinoma. PMID: 29946224 Ref: A Novel Monoclonal Antibody Targets Mucin1 and Attenuates Growth in Pancreatic Cancer Model. PMID: 29987260 Ref: Intrapancreatic recurrence of intraductal tubulopapillary neoplasm (ITPN) 16 years after the initial surgery for noninvasive ITPN: a case report. PMID: 30116990 Ref: Rationale and feasibility of mucin expression profiling by qRT-PCR as diagnostic biomarkers in cytology specimens of pancreatic cancer. PMID: 30268674 |